Hjem › Multippel sklerose › Kansas
Kliniske studier for Multippel sklerose i Kansas
9 studier for Multippel sklerose søker deltakere på steder i Kansas.
Byer i Kansas
Offisiell studietekst (engelsk)
A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity
- University of Kansas Medical Center, Kansas City
RekruttererFase 2
Alder 18 til 70 · Alle kjønn · Oppdatert 1. okt. 2026 · NCT06782490Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- University of Kansas Clinical Research Center, Fairway
- HaysMed, Hays
- University of Kansas Cancer Center, Kansas City
- og 7 flere
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 23. sep. 2026 · NCT03816345A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
- TG Therapeutics Investigational Trial Site, Roeland Park
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 23. sep. 2026 · NCT06433752Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis
- University of Kansas Medical Center, Kansas City
RekruttererFase 1/2
Alder 18 til 65 · Alle kjønn · Oppdatert 21. sep. 2026 · NCT07477639RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- The University of Kansas Medical Center, Kansas City
RekruttererFase 2
Alder 18 til 80 · Alle kjønn · Oppdatert 15. sep. 2026 · NCT07002034A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
- University of Kansas Hospital, Kansas City
RekruttererFase 3
Alder 18 til 65 · Alle kjønn · Oppdatert 29. jul. 2026 · NCT07225504Efficacy of Cognitive Behavioral Therapy for Insomnia to Treat Insomnia Symptoms in Individuals With Multiple Sclerosis
- University of Kansas Medical Center, Kansas City
RekruttererFase 2
Alder 18 til 65 · Alle kjønn · Oppdatert 12. jun. 2026 · NCT06428006Comparing Telehealth-Delivered CBT-I to Web-Based CBT-I to Enhance Sleep, Reduce Fatigue, and Promote Neuroprotection
- University of Kansas Medical Center- Sleep, Health and Wellness Laboratory, Kansas City
RekruttererFase 2
Alder 18 til 65 · Alle kjønn · Oppdatert 9. okt. 2025 · NCT06434571Dry Needling in Multiple Sclerosis
- Mobility and Falls Lab, Kansas City
Rekrutterer
Alder 18 til 64 · Alle kjønn · Oppdatert 11. jun. 2025 · NCT06394310Fra ClinicalTrials.gov, data hentet 4. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.